Compound Detail
CHEMBL48614
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL48614 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BXCQAEHFWJFGAT-YVLHZVERSA-N |
6
Targets
8
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names
Molecular Properties
385.9
MW (Da)
4.18
ALogP
5
HBA
2
HBD
70.0
PSA (Ų)
0.76
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 8 meas. best 6.22
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cyclin-dependent kinase 1 CHEMBL308 | IC50 | 6.22 | 6.22 | 600.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 5.78 | 5.78 | 1680.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 5.4 | 5.4 | 3970.0 | 3 |
| Glycogen synthase kinase-3 CHEMBL2095188 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 4.7 | 4.7 | 20100.0 | 1 |
| Cyclin-dependent kinase 4 CHEMBL331 | IC50 | 4.6 | 4.6 | 25250.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Cyclin-dependent kinase 1 | IC50 | = | 600.0 | nM | 6.22 | Inhibition of cyclin B activated Cyclin-dependent kinase 1 (CDK1) | 11960485 |
| Epidermal growth factor receptor | IC50 | = | 1680.0 | nM | 5.78 | Inhibition of Epidermal growth factor receptor | 11960485 |
| Cyclin-dependent kinase 2 | IC50 | = | 3970.0 | nM | 5.4 | Evaluated for inhibition of human cyclin dependent kinase 2 (CDK2) | 15115396 |
| Cyclin-dependent kinase 2 | IC50 | = | 3970.0 | nM | 5.4 | Inhibition of cyclin A activated Cyclin-dependent kinase 2 (CDK2) | 11960485 |
| Cyclin-dependent kinase 2 | IC50 | = | 3970.0 | nM | 5.4 | Inhibition of Cyclin-dependent kinase 2 (CDK2) | 12852762 |
| Glycogen synthase kinase-3 | IC50 | = | 10000.0 | nM | 5.0 | inhibition of Glycogen synthase kinase-3 | 11960485 |
| HCT-116 | IC50 | = | 20100.0 | nM | 4.7 | Inhibition of HCT116 (transformed colon) cell proliferation | 11960485 |
| Cyclin-dependent kinase 4 | IC50 | = | 25250.0 | nM | 4.6 | Inhibition of cyclin D1 activated Cyclin-dependent kinase 4 (CDK4) | 11960485 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15115396 | 10.1021/jm0304358 | Cyclin-dependent kinase 2 | 1 |
| 11960485 | 10.1021/jm0108348 | Cyclin-dependent kinase 1 | 1 |
| 11960485 | 10.1021/jm0108348 | Cyclin-dependent kinase 2 | 1 |
| 11960485 | 10.1021/jm0108348 | Cyclin-dependent kinase 4 | 1 |
| 11960485 | 10.1021/jm0108348 | Glycogen synthase kinase-3 | 1 |
| 11960485 | 10.1021/jm0108348 | Protein kinase C alpha type | 1 |
| 11960485 | 10.1021/jm0108348 | Vascular endothelial growth factor receptor 2 | 1 |
| 11960485 | 10.1021/jm0108348 | Epidermal growth factor receptor | 1 |
| 11960485 | 10.1021/jm0108348 | HCT-116 | 1 |
| 12852762 | 10.1021/jm0205043 | Cyclin-dependent kinase 2 | 1 |
Data from ChEMBL 36 via Core Engine